Vice President North Carolina

Rachmuth, Guy

Guy Rachmuth, Ph.D.

Raleigh-Durham, North Carolina

********@****.*******.*** 617-***-****

linkedin.com/in/guyrachmuth

OVERVIEW

General management Strategy execution Corporate development Mergers and Acquisitions Competitive Intelligence P&L management Commercial Strategy Integration Product Development Innovation Biomedical engineering background Ph.D. Harvard University Seeking a Senior VP, Executive Vice President, Chief Strategy Officer or Chief Executive Officer role in Life Sciences, healthcare, medical devices and healthcare technology CAREER SUMMARY

Dynamic senior operator with over 20 years of leadership experience in corporate development, strategic planning and commercial execution. Proven track record in generating +$100M in annual incremental revenue through strategic M&A initiatives and enterprise-wide organic growth strategies. Successfully directed capital investments exceeding $50M, leading to substantial growth. Founder of two start-ups, served as CEO and CTO for both, and focused on artificial intelligence-led healthcare technologies. Expertise in competitive intelligence and market landscape analysis. Adept at fostering strategic partnerships globally, including China and Japan. CAREER EXPERIENCE

IQVIA (NYSE: IQV). Durham, North Carolina (2013 – Present) Public, Fortune 200 company; World's largest provider of technology and outsourced solutions for biopharmaceutical clinical development and commercial services with ~90,000 employees in 100 countries. VICE PRESIDENT, CORPORATE STRATEGY – ENTERPRISE (6/2021 to Present) Direct report to CFO and a member of the Senior Leadership Team (SLT) (top 20 leaders out of 90,000). A pivotal orchestrator in driving a coherent enterprise strategy integrating FP&A, Investor Relations, M&A and Global Business Units perspectives.

• Contributed to achieving yearly high-impact M&A transactions (incremental ~$200M/yr)

• Led Generative AI initiative across enterprise – resulted in 2 AI-enabled commercial offerings, created marketing strategy and initiated partnership discussions with NVIDIA and other players

• Executed Salesforce deal by leading strategic rationale and negotiations - resulted in 7+ year deal

• Delivered weekly competitive intelligence analysis covering over 200 companies in life sciences

• Orchestrated market landscapes and strategic “white spaces” analysis for segment-level M&A activities

Rachmuth, Guy

VICE PRESIDENT, STRATEGY AND CORPORATE DEVELOPMENT - IQVIA LABORATORIES (formerly Q2 Solutions) (9/2015 to 6/2021)

Joint venture between IQVIA (NYSE: IQV) and Quest Diagnostics (NYSE: DGX) focused clinical trials; Founded July 2015; IQVIA acquired remaining 40% ownership April 2021. Chief Strategy Officer and member of Executive Team reporting to CEO.

• Key member of the team that founded Q2 Solutions, and the team that led to the acquisition of Q2 Solutions (now IQVIA Laboratories) – oversaw strategy and corporate development during the entire company life cycle – saw growth from +$600 to +$1B in revenue in that span.

• Led and executed M&A of companies in growth segments with deal values +$900M across several new areas including discovery services and logistics technology offerings.

• Directed the deployment of >$50M in CapEx, driving product and offering development teams in genomics and personalized medicine, as well as vaccines development in response to pandemic.

• Signed collaboration partnerships with local China and Japan lab companies to drive market leadership.

DIRECTOR, STRATEGIC PLANNING - Quintiles CRO (7/2013 to 9/2015)

• Reported to President of clinical development. Led strategic planning for clinical research organization ($2B+ in revenues), driving $100m+ of investment capital allocation – drove yearly strategic plans for patient recruitment, clinical monitoring, and laboratory services. M*Modal, Morrisville, North Carolina (1/2012 – 6/2013) A $500M provider of clinical documentation solutions for physicians using NLP / Machine Learning and artificial intelligence. Healthcare technology solution business was acquired by 3M. DIRECTOR, HEALTHCARE DATA STRATEGY & CORPORATE BUSINESS DEVELOPMENT Lead and executed the company's strategic plan with a focus on M&A and joint partnerships. Reported to Chief Strategy Officer and Corporate Development SVP

• Developed information offerings for payers, contract research organizations (CRO's) and life sciences companies, increasing the addressable market by $5B.

• Increase partnerships from 3 to 12, and increased revenue through the execution of multiple commercialization programs in 14 months.

HEALTHeME Inc. Durham, North Carolina (5/2009-12/2011) Founded a mobile health (mHealth) Software-as-a-Service (SaaS) company focused on artificial intelligence solutions managing chronic conditions such as obesity, diabetes and heart disease. CO-FOUNDER, CHIEF EXECUTIVE OFFICER, CHIEF TECHNOLOGY OFFICER Chief executive officer, led product development, P&L management, Board engagement & VC fund raising, Rachmuth, Guy

• Drove the commercial strategy, encompassing sales management, marketing, and product development to enhance market penetration. Recruited and managed a diverse team of 20 professionals, fostering a collaborative work environment.

• Raised 2 rounds of funding (~$1M) that funded company for 3 years.

• Signed major clients including insurance companies and life science corporations covering 10,000 users

Nucryst Pharmaceuticals (acquired by Smith & Nephew) (1/2008 – 7/2009) DIRECTOR, CORPORATE DEVELOPMENT (2008-2009)

• Led in-licensing and out-licensing portfolio. Managed patent estate of over 200 patents.

• Executed company sales process (one of two employees that remained through integration) NeuroAnalogICs Inc., (6/2005 to 12/2007)

FOUNDER, CHIEF EXECUTIVE OFFICER, CHIEF OF PRODUCT DEVELOPMENT

• Developed hardware chips with embedded artificial intelligence to help patients with Parkinson’s and epilepsy. Filed 2 patents, raised SBIR grants to fund operations, and participated in Sloan School of management competitions to raise VC funding. Concurrent with post-doc at MIT. EDUCATION AND CREDENTIALS

Professional Development: Completed coursework through Sloan School of Management (MIT) and Harvard Business School towards MBA: Biomedical Enterprise Program. Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts POST-DOCTORATE IN ARTIFICIAL INTELLIGENCE AND NEURO-MORPHIC ENGINEERING

• Invented artificial intelligence (AI) technology awarded one of the “Best in 2011” by MIT.

• Scientific publication was covered by Forbes, WSJ, MSNBC, BBC and others in Nov-Dec 2011 Harvard University, Cambridge, Massachusetts

• Ph.D. IN BIOMEDICAL ENGINEERING

• National Defense and Engineering Graduate Fellowship via DoD (5% award rate, $200,000 value)

• Thesis: “VLSI Circuit models of Neuronal Dynamics and Synaptic Plasticity”

• Published 12 papers in top scientific journals

• 2 issued US Patents 7,714,762; 8,504,503

Harvard University, Cambridge, Massachusetts

• MASTER OF SCIENCE IN BIOMEDICAL ENGINEERING

• Focused on robotics, artificial intelligence and healthcare analytics in biological systems Boston University, Boston, Massachusetts

• BACHELOR OF SCIENCE IN BIOMEDICAL ENGINEERING

• SUMMA CUM LAUDE (3.9+ GPA)

Contact this candidate